Proposed model for a mechanism of action underlying the protective effects of VSL#3 probiotic bacteria in mouse models of gut inflammation and cancer.

Role of microbiota and gut inflammation in the pathogenesis of experimental colorectal cancer

Klimešová, Klára

January 2012

Mucosal surface of the gut is in continuous contact with foreign compounds derived from diet as well...

Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology

Karen Madsen
Anthony Cornish
Paul Soper
Conor Mckaigney
Humberto Jijon
Christine Yachimec
Jason Doyle
Lawrence Jewell
Claudio De Simone

January 2001

efficacious as maintenance therapy in pouchitis and ulcerative colitis. The aim of this study was to...

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.

Andrea Mencarelli
Sabrina Cipriani
Barbara Renga
Angela Bruno
Claudio D'Amore
Eleonora Distrutti
Stefano Fiorucci

BACKGROUND: Signals generated by the inflammed intestine are thought to contribute to metabolic dera...

Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.

Bassaganya-Riera, Josep
Viladomiu, Monica
Pedragosa, Mireia
De Simone, Claudio
Carbo, Adria
Shaykhutdinov, Rustem
Jobin, Christian
Arthur, Janelle C.
Corl, Benjamin A.
Vogel, Hans
Storr, Martin
Hontecillas, Raquel

January 2012

Inflammatory bowel disease (IBD) therapies are modestly successful and associated with significant s...

Probiotic Bacteria Produce Conjugated Linoleic Acid Locally in the Gut That Targets Macrophage PPAR γ to Suppress Colitis

Josep Bassaganya-Riera (120051)
Monica Viladomiu (120075)
Mireia Pedragosa (120080)
Claudio De Simone (171437)
Adria Carbo (120066)
Rustem Shaykhutdinov (182227)
Christian Jobin (74703)
Janelle C. Arthur (143340)
Benjamin A. Corl (182236)
Hans Vogel (182237)
Martin Storr (124415)
Raquel Hontecillas (120113)

February 2012

<div><h3>Background</h3><p>Inflammatory bowel disease (IBD) therapies are modestly successful and as...

Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria.

Josep Bassaganya-Riera
Monica Viladomiu
Mireia Pedragosa
Claudio De Simone
Raquel Hontecillas

BACKGROUND: Inflammatory bowel disease (IBD) increases the risk of colorectal cancer. Probiotic bact...

Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria

Josep Bassaganya-Riera (120051)
Monica Viladomiu (120075)
Mireia Pedragosa (120080)
Claudio De Simone (171437)
Raquel Hontecillas (120113)

April 2012

<div><h3>Background</h3><p>Inflammatory bowel disease (IBD) increases the risk of colorectal cancer....

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer

Arthur, Janelle C.
Gharaibeh, Raad Z.
Uronis, Joshua M.
Perez-Chanona, Ernesto
Sha, Wei
Tomkovich, Sarah
Mühlbauer, Marcus
Fodor, Anthony A.
Jobin, Christian

January 2013

Although probiotics have shown success in preventing the development of experimental colitis-associa...

The probiotic mixture VSL#3 has differential effects on intestinal immune parameters in healthy female BALB/c and C57BL/6 mice

Mariman, R.
Tielen, F.
Koning, F.
Nagelkerken, L.

January 2015

Background: Probiotic bacteria may render mice resistant to the development of various inflammatory ...

The Probiotic Mixture VSL#3 Has Differential Effects on Intestinal Immune Parameters in Healthy Female BALB/c and C57BL/6 Mice1–3

Nutritional Immunology
Rob Mariman
Frans Tielen
Frits Koning
Lex Nagelkerken

October 2016

Background: Probiotic bacteria may render mice resistant to the development of various inflammatory ...

RESEARCH ARTICLE The Probiotic Mixture VSL#3 Dampens LPS-Induced Chemokine Expression in

Human Dendritic
Cells Inhibition
Rob Mariman
Frans Tielen
Frits Koning
Lex Nagelkerken
Citation Mariman R
Tielen F
Koning F

October 2016

VSL#3, a mixture of 8 different probiotic bacteria, has successfully been used in the clinic to trea...

VSL#3 and conjugated linoleic acid (CLA) modulate colonic gene expression.

Josep Bassaganya-Riera (120051)
Monica Viladomiu (120075)
Mireia Pedragosa (120080)
Claudio De Simone (171437)
Raquel Hontecillas (120113)

April 2012

<p>C57BL/6J mice (n = 60) were treated with the VSL#3 probiotic (n = 20), CLA-supplemented (1 g/100 ...

Probiotic colonization dynamics after oral consumption of VSL#3® by antibiotic-treated mice

Theriot, Casey
Thanissery, Rajani
O'Flaherty, Sarah
Barrangou, Rodolphe

July 2022

Background: The ability of probiotic strains to provide health benefits to the host partially hinges...

Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model

Jena, Prasant Kumar
Sheng, Lili
Li, Yongchun
Wan, Yui-Jui Yvonne

April 2020

BackgroundProbiotic VSL#3 is used to treat ulcerative colitis. This study examines the effect of VSL...

Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics

Celiberto, Larissa S.
Pinto, Roseli Aparecida
Rossi, Elizeu Antonio
Vallance, Bruce A.
Cavallini, Daniela C. U.

April 2019

Modulation of the gut microbiota through the use of probiotics has been widely used to treat or prev...

Role of microbiota and gut inflammation in the pathogenesis of experimental colorectal cancer

Klimešová, Klára

January 2012

Mucosal surface of the gut is in continuous contact with foreign compounds derived from diet as well...

Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology

Karen Madsen
Anthony Cornish
Paul Soper
Conor Mckaigney
Humberto Jijon
Christine Yachimec
Jason Doyle
Lawrence Jewell
Claudio De Simone

January 2001

efficacious as maintenance therapy in pouchitis and ulcerative colitis. The aim of this study was to...

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.

Andrea Mencarelli
Sabrina Cipriani
Barbara Renga
Angela Bruno
Claudio D'Amore
Eleonora Distrutti
Stefano Fiorucci

BACKGROUND: Signals generated by the inflammed intestine are thought to contribute to metabolic dera...

Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.

Bassaganya-Riera, Josep
Viladomiu, Monica
Pedragosa, Mireia
De Simone, Claudio
Carbo, Adria
Shaykhutdinov, Rustem
Jobin, Christian
Arthur, Janelle C.
Corl, Benjamin A.
Vogel, Hans
Storr, Martin
Hontecillas, Raquel

January 2012

Inflammatory bowel disease (IBD) therapies are modestly successful and associated with significant s...

Probiotic Bacteria Produce Conjugated Linoleic Acid Locally in the Gut That Targets Macrophage PPAR γ to Suppress Colitis

Josep Bassaganya-Riera (120051)
Monica Viladomiu (120075)
Mireia Pedragosa (120080)
Claudio De Simone (171437)
Adria Carbo (120066)
Rustem Shaykhutdinov (182227)
Christian Jobin (74703)
Janelle C. Arthur (143340)
Benjamin A. Corl (182236)
Hans Vogel (182237)
Martin Storr (124415)
Raquel Hontecillas (120113)

February 2012

<div><h3>Background</h3><p>Inflammatory bowel disease (IBD) therapies are modestly successful and as...

Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria.

Josep Bassaganya-Riera
Monica Viladomiu
Mireia Pedragosa
Claudio De Simone
Raquel Hontecillas

BACKGROUND: Inflammatory bowel disease (IBD) increases the risk of colorectal cancer. Probiotic bact...

Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria

Josep Bassaganya-Riera (120051)
Monica Viladomiu (120075)
Mireia Pedragosa (120080)
Claudio De Simone (171437)
Raquel Hontecillas (120113)

April 2012

<div><h3>Background</h3><p>Inflammatory bowel disease (IBD) increases the risk of colorectal cancer....

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer

Arthur, Janelle C.
Gharaibeh, Raad Z.
Uronis, Joshua M.
Perez-Chanona, Ernesto
Sha, Wei
Tomkovich, Sarah
Mühlbauer, Marcus
Fodor, Anthony A.
Jobin, Christian

January 2013

Although probiotics have shown success in preventing the development of experimental colitis-associa...

The probiotic mixture VSL#3 has differential effects on intestinal immune parameters in healthy female BALB/c and C57BL/6 mice

Mariman, R.
Tielen, F.
Koning, F.
Nagelkerken, L.

January 2015

Background: Probiotic bacteria may render mice resistant to the development of various inflammatory ...

The Probiotic Mixture VSL#3 Has Differential Effects on Intestinal Immune Parameters in Healthy Female BALB/c and C57BL/6 Mice1–3

Nutritional Immunology
Rob Mariman
Frans Tielen
Frits Koning
Lex Nagelkerken

October 2016

Background: Probiotic bacteria may render mice resistant to the development of various inflammatory ...

RESEARCH ARTICLE The Probiotic Mixture VSL#3 Dampens LPS-Induced Chemokine Expression in

Human Dendritic
Cells Inhibition
Rob Mariman
Frans Tielen
Frits Koning
Lex Nagelkerken
Citation Mariman R
Tielen F
Koning F

October 2016

VSL#3, a mixture of 8 different probiotic bacteria, has successfully been used in the clinic to trea...

VSL#3 and conjugated linoleic acid (CLA) modulate colonic gene expression.

Josep Bassaganya-Riera (120051)
Monica Viladomiu (120075)
Mireia Pedragosa (120080)
Claudio De Simone (171437)
Raquel Hontecillas (120113)

April 2012

<p>C57BL/6J mice (n = 60) were treated with the VSL#3 probiotic (n = 20), CLA-supplemented (1 g/100 ...

Probiotic colonization dynamics after oral consumption of VSL#3® by antibiotic-treated mice

Theriot, Casey
Thanissery, Rajani
O'Flaherty, Sarah
Barrangou, Rodolphe

July 2022

Background: The ability of probiotic strains to provide health benefits to the host partially hinges...

Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model

Jena, Prasant Kumar
Sheng, Lili
Li, Yongchun
Wan, Yui-Jui Yvonne

April 2020

BackgroundProbiotic VSL#3 is used to treat ulcerative colitis. This study examines the effect of VSL...

Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics

Celiberto, Larissa S.
Pinto, Roseli Aparecida
Rossi, Elizeu Antonio
Vallance, Bruce A.
Cavallini, Daniela C. U.

April 2019

Modulation of the gut microbiota through the use of probiotics has been widely used to treat or prev...

Role of microbiota and gut inflammation in the pathogenesis of experimental colorectal cancer

Klimešová, Klára

January 2012

Mucosal surface of the gut is in continuous contact with foreign compounds derived from diet as well...

Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology

Karen Madsen
Anthony Cornish
Paul Soper
Conor Mckaigney
Humberto Jijon
Christine Yachimec
Jason Doyle
Lawrence Jewell
Claudio De Simone

January 2001

efficacious as maintenance therapy in pouchitis and ulcerative colitis. The aim of this study was to...

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.

Andrea Mencarelli
Sabrina Cipriani
Barbara Renga
Angela Bruno
Claudio D'Amore
Eleonora Distrutti
Stefano Fiorucci

BACKGROUND: Signals generated by the inflammed intestine are thought to contribute to metabolic dera...

Proposed model for a mechanism of action underlying the protective effects of VSL#3 probiotic bacteria in mouse models of gut inflammation and cancer.

Abstract

Extracted data

Proposed model for a mechanism of action underlying the protective effects of VSL#3 probiotic bacteria in mouse models of gut inflammation and cancer.

Abstract

Extracted data

Related items

Related items